Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4+ and CD8+ T cells with a T-helper 1 profile

Immunology

Volumn 132, Issue 2, 2011, Pages 174-187

  Garro, Ana P ^a   Chiapello, Laura S ^a   Baronetti, José L ^a   Masih, Diana T ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Antigen presentation; Cryptococcus neoformans; Eosinophils; T helper 1 (Th1) profile

Indexed keywords

B7 ANTIGEN; CD18 ANTIGEN; CD86 ANTIGEN; FC GAMMA RII; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DOWN REGULATION; EOSINOPHIL; IMMUNE RESPONSE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TH1 CELL; UPREGULATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; EOSINOPHILS; HUMANS; INTERFERON-GAMMA; MALE; PHAGOCYTOSIS; RATS; RATS, WISTAR; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650945973     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03351.x     Document Type: Article

References (49)

1. Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 2000; 68:4225-37.
2. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37:3204-9.
3. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62:4755-61.
4. + T cells. J Exp Med 1991; 173:793-800.
5. Huffnagle GB, Toews GB, Burdick MD et al. Afferent phase production of TNFα is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996; 157:4529-36.
6. Rossi GR, Cervi LA, Garcia MM, Chiapello LS, Sastre DA, Masih DT. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin Immunol 1999; 90:256-65.
7. Rossi GR, Sastre DA, Rubinstein HR, Masih DT. Biochemical basis for the killing of Cryptococcus neoformans by rat peritoneal cells. J Med Vet Mycol 1994; 32:405-14.
8. Serradell MC, Guasconi L, Masih DT. Involvement of a mitochondrial pathway and key role of hydrogen peroxide during eosinophil apoptosis induced by excretory-secretory products from Fasciola hepatica. Mol Biochem Parasitol 2009; 163:95-106.
9. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-74.
10. + Th2 lymphocyte function. J Immunol 2001; 167:3146-55.
11. Xie ZF, Shi HZ, Qin XJ, Kang LF, Huang CP, Chen YQ. Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005; 118:6-11.
12. Shi HZ, Xiao CQ, Li CQ et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 2004; 59:428-35.
13. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006; 74:3232-8.
14. Padigel UM, Hess JA, Lee JJ et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007; 196:1844-51.
15. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105:945-53.
16. Shi HZ. Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004; 76:520-7.
17. Schermoly MJ, Hinthorn DR. Eosinophilia in coccidioidomycosis. Arch Intern Med 1988; 148:895-6.
18. Wagner JM, Franco M, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions. Am J Trop Med Hyg 1998; 59:66-72.
19. Feldmesser M, Casadevall A, Kress Y, Spira G, Orlofsky A. Eosinophils-Cryptococcus neoformans interactions in vivo and in vitro. Infect Immun 1997; 65:1899-907.
20. Chiapello L, Iribarren P, Cervi L, Rubinstein H, Masih DT. Mechanisms for induction of immunosuppression during experimental cryptococcosis. Role of glucuronoxylomannan. Clin Immunol 2001; 100:96-106.
21. Chiapello LS, Aoki MP, Rubinstein HR, Masih DT. Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans. Med Mycol 2003; 41:347-53.
22. Chiapello LS, Baronetti JL, Aoki MP, Rubinstein HR, Masih DT. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 2004; 113:392-400.
23. Chiapello LS, Baronetti JL, Garro AP, Spesso MF, Masih DT. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immunol 2008; 20:1527-41.
24. Sedgwick JB, Shikama Y, Nagata M, Brener K, Busse WW. Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods 1996; 198:15-24.
25. Taborda CP, Casadevall A. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 2002; 16:791-802.
26. Chaturvedi R, Cheng Y, Asim M et al. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem 2004; 279:40161-73.
27. Del PV, De AB, Martín E et al. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 1992; 22:1919-25.
28. Moreno J, Lipsky PE. Functional heterogeneity of human antigen-presenting cells: presentation of soluble antigen but not self-Ia by monocytes. J Clin Immunol 1986; 6:9-20.
29. Baronetti JL, Chiapello LS, Aoki MP, Gea S, Masih DT. Heat killed cells of Cryptococcus neoformans var. grubii induce protective immunity in rats: immunological and histopathological parameters. Med Mycol 2006; 44:493-504.
30. Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR. Encapsulation of Cryptococcus neoformans with Glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect Immun 1998; 66:664-9.
31. Syme RM, Spurrell JCL, Amankwah EK, Green FHY, Mody CH. Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptor and Fcγ receptor II for presentation to T lymphocytes. Infect Immun 2002; 70:5972-81.
32. Monari C, Bistoni F, Casadevall A, Periconili E, Pietrella D, Kozel TR, Vecchiarelli A. Glucuronoxylomannan, a microbial compound, regulates expresion of costimulatory molecules and cytokine production in macrophages. J Infect Dis 2005; 191:127-37.
33. Sabin EA, Kopf MA, Pearce EJ. Schistosoma mansoni egg induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996; 184:1871-8.
34. Lee JJ, Dimina D, Macias MP et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305:1773-6.
35. Chen GH, Olszewski MA, McDonald RA et al. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 2007; 170:1028-40.
36. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623.
37. Greenberg S. Modular components of phagocytosis. J Leukoc Biol 1999; 66:712-7.
38. Hatano Y, Taniuchi S, Masuda M et al. Phagocytosis of heat-killed Staphylococcus aureus by eosinophils: comparison with neutrophils. APMIS 2009; 117:115-23.
39. Phipps S, Lam C, Mahalingam S et al. Eosinophils contribute to innate immunity and promote clearance of respiratory syncytial virus. Blood 2007; 110:1578-86.
40. Aguirre KM, Gibson GW. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med Mycol 2000; 38:343-53.
41. Snelgrove RJ, Edwards L, Williams AE, Rae AJ, Hussell T. In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection. J Immunol 2006; 177:5509-16.
42. Kawakami K, Zhang T, Qureshi MH, Saito A. Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-γ and lipopolysaccharide. Cell Immunol 1997; 180:47-54.
43. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55:35-42.
44. Handzel ZT, Busse WW, Sedgwick JB et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998; 160:1279-84.
45. Davoine F, Min C, Yingqi W et al. Virus-induced eosinophil mediator release requires antigen presenting and CD4+ T cells. J Allergy Clin Immunol 2008; 122:69-77.
46. Yada A, Ebihara S, Matsumura K et al. Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell Immunol 2003; 225:21-32.
47. Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 2001; 9:273-8.
48. + T cells during Cryptococcus neoformans infection. J Immunol 2005; 174:7920-8.
49. Mody CH, Paine R III, Jackson C, Chen CH, Toewst CB. CD8 cells play a critical role in delayed type hypersensitivity to intact Crypfococcus neoformans. J Immunol 1994; 152:3970-9.